Back to Topics Listing
May 27, 2016
Powell K, Walker RW, Rogathe J, Gray WK, Hunter E, Newton CR, Burton K
OBJECTIVES: Eighty-five percent of the 33 million children with epilepsy (CWE) worldwide live in low- and middle-income countries (LMICs). There is limited research into epilepsy-related comorbidities in LMICs, and the...
May 27, 2016
Deck GM, Nadkarni N, Montouris GD, Lovett A
OBJECTIVE: The aim of this study was to determine the frequency of association of major congenital malformations in pregnancy in women exposed to antiepileptic drugs (AEDs) in an inner city population. BACKGROU...
May 27, 2016
Tan M, Wilson I, Braganza V, Ignatiadis S, Boston R, Sundararajan V, Cook MJ, D'Souza WJ
OBJECTIVES: We report the diagnostic validity of a selection algorithm for identifying epilepsy cases. STUDY DESIGN AND SETTING: Retrospective validation study of International Classification of Diseases 10th R...
May 27, 2016
Bustos JA, García HH, Del Brutto OH
INTRODUCTION: Neurocysticercosis (NCC) is a leading causes of secondary epilepsy worldwide. There is increasing evidence on the epileptogenic role of NCC, and the presence of edema, calcified scars, gliosis and hippoca...
May 24, 2016
Franzoni E, Matricardi S, Di Pisa V, Capovilla G, Romeo A, Tozzi E, Pruna D, Salerno GG, Zamponi N, Accorsi P, Giordano L, Coppola G, Cerminara C, Curatolo P, Nicita F, Spalice A, Grosso S, Pavone P, Striano P, Parisi P, Boni A, Gobbi G, Carotenuto M, Esposito M, Cottone C, Verrotti A
BACKGROUND: To evaluate evidence and prognosis of refractory cases of absence seizures. METHODS: Subjects with refractory absence seizures were identified retrospectively in 17 Italian epilepsy pediatrics Cente...
May 24, 2016
Krauss G, Sandy S, Corbin DO, Bird-Compton J, Jack F, Nelson B, Jalonen TO, Ali A, Fortuné T, Clarke D, Okolie J, Cervenka MC
Very little has been reported about the health resources available for patients with epilepsy in the five English-speaking southern Caribbean countries of Trinidad and Tobago, Barbados, Grenada, Saint Vincent and the G...
May 22, 2016
Pellock JM, Faught E, Foroozan R, Sergott RC, Shields WD, Ziemann A, Lee D, Dribinsky Y, Torri S, Othman F, Isojarvi J
Vigabatrin (Sabril®) is an antiepileptic drug (AED) currently indicated in the US as a monotherapy for patients 1month to 2years of age with infantile spasms (IS) and as adjunctive therapy for patients ≥10years of age ...
May 22, 2016
Charalambous M, Shivapour SK, Brodbelt DC, Volk HA
BACKGROUND: The safety profile of anti-epileptic drugs (AEDs) is an important consideration for the regulatory bodies, owners and prescribing clinicians. Information on their adverse effects still remains limited. A sy...
May 21, 2016
Rzezak P, Lima EM, Pereira F, Gargaro AC, Coimbra E, de Vincentiis S, Velasco TR, Leite JP, Busatto GF, Valente KD
BACKGROUND: Decision-making abilities have rarely been examined in patients with temporal lobe epilepsy related to hippocampal sclerosis (TLE-HS). We aimed to investigate the ability to delay gratification, a decision-...
May 21, 2016
de Toffol B, Kanemoto K
Psychosis in epilepsy can be categorized in relation to seizures in two main categories: interictal psychosis and postictal psychosis. Postictal psychosis (PIP) is a specific syndrome in relation to seizure activity: a...

Pages